2.950
2.95 (0%)
As of Dec 20, 2024
Soligenix, Inc. [SNGX]
Source:
Company Overview
Soligenix, Inc is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. We maintain two active business segments: Specialized BioTherapeutics and Public Health Solutions.
Country | United States |
Headquarters | princeton, new jersey |
Phone Number | ( 609 ) 538-8200 |
Industry | manufacturing |
CEO | Christopher J. Schaber |
Website | www.soligenix.com |